Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-02

Clinical Trial Update: Effect of Oxalidine Combined with Reduced-opioid Anesthesia on Multimodal Analgesia in Morbidly Obese Patients Undergoing Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical study evaluating Oxalidine with reduced-opioid anesthesia to improve multimodal analgesia in morbid obesity patients undergoing bariatric surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxalidine (Oxalidine)

Snippet

Sponsor: Yongtao Sun | Conditions: Morbid Obesity | Phase 4 | Status: NOT_YET_RECRUITING